Gateway Investment Advisers LLC Biogen Inc. Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Biogen Inc. stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 41,312 shares of BIIB stock, worth $7.18 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

41,312

Previous 41,389 0.19%

Holding current value

$7.18 Million

Previous $9.59 Million 16.54%

% of portfolio

0.09%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$189.07 - $236.8 $14,558 - $18,233	-77 Reduced 0.19%	41,312 $8.01 Million
Q2 2024 Jul 12, 2024	SELL	$190.52 - $236.72 $8,573 - $10,652	-45 Reduced 0.11%	41,389 $9.59 Million
Q1 2024 Apr 12, 2024	SELL	$212.02 - $267.71 $1.17 Million - $1.47 Million	-5,505 Reduced 11.73%	41,434 $8.93 Million
Q4 2023 Jan 09, 2024	SELL	$222.59 - $267.94 $1.31 Million - $1.58 Million	-5,897 Reduced 11.16%	46,939 $12.1 Million
Q3 2023 Oct 19, 2023	SELL	$253.3 - $285.89 $39,514 - $44,598	-156 Reduced 0.29%	52,836 $13.6 Million
Q2 2023 Jul 13, 2023	SELL	$275.25 - $318.06 $3.7 Million - $4.28 Million	-13,444 Reduced 20.24%	52,992 $15.1 Million
Q1 2023 Apr 11, 2023	BUY	$256.56 - $292.34 $2.57 Million - $2.93 Million	10,014 Added 17.75%	66,436 $18.5 Million
Q4 2022 Jan 13, 2023	SELL	$252.44 - $306.72 $3.63 Million - $4.42 Million	-14,395 Reduced 20.33%	56,422 $0
Q3 2022 Oct 07, 2022	SELL	$194.69 - $268.46 $14,991 - $20,671	-77 Reduced 0.11%	70,817 $18.9 Million
Q2 2022 Jul 13, 2022	BUY	$187.54 - $223.02 $2.14 Million - $2.54 Million	11,395 Added 19.15%	70,894 $14.5 Million
Q1 2022 Apr 14, 2022	BUY	$193.77 - $244.14 $865,958 - $1.09 Million	4,469 Added 8.12%	59,499 $12.5 Million
Q4 2021 Jan 14, 2022	SELL	$223.92 - $287.77 $1.52 Million - $1.95 Million	-6,782 Reduced 10.97%	55,030 $13.2 Million
Q3 2021 Oct 22, 2021	BUY	$282.99 - $369.05 $565 - $738	2 Added 0.0%	61,812 $17.5 Million
Q2 2021 Jul 13, 2021	SELL	$259.0 - $414.71 $68,376 - $109,483	-264 Reduced 0.43%	61,810 $21.4 Million
Q1 2021 Apr 14, 2021	SELL	$242.95 - $284.63 $1.39 Million - $1.63 Million	-5,733 Reduced 8.45%	62,074 $17.4 Million
Q4 2020 Jan 14, 2021	SELL	$236.26 - $355.63 $447,712 - $673,918	-1,895 Reduced 2.72%	67,807 $16.6 Million
Q3 2020 Oct 19, 2020	SELL	$264.77 - $305.71 $3.09 Million - $3.57 Million	-11,671 Reduced 14.34%	69,702 $19.8 Million
Q2 2020 Jul 15, 2020	SELL	$258.66 - $342.55 $1.74 Million - $2.3 Million	-6,718 Reduced 7.63%	81,373 $21.8 Million
Q1 2020 Apr 13, 2020	SELL	$268.85 - $341.04 $2.17 Million - $2.75 Million	-8,071 Reduced 8.39%	88,091 $27.9 Million
Q4 2019 Jan 09, 2020	SELL	$220.06 - $304.07 $5.87 Million - $8.12 Million	-26,693 Reduced 21.73%	96,162 $28.5 Million
Q3 2019 Oct 15, 2019	SELL	$217.44 - $243.88 $3.77 Million - $4.23 Million	-17,348 Reduced 12.37%	122,855 $28.6 Million
Q2 2019 Jul 17, 2019	BUY	$219.29 - $241.72 $2.83 Million - $3.12 Million	12,889 Added 10.12%	140,203 $32.8 Million
Q1 2019 Apr 10, 2019	SELL	$216.71 - $338.96 $195,039 - $305,064	-900 Reduced 0.7%	127,314 $30.1 Million
Q4 2018 Jan 14, 2019	BUY	$278.5 - $352.75 $2.05 Million - $2.59 Million	7,351 Added 6.08%	128,214 $38.6 Million
Q3 2018 Oct 16, 2018	SELL	$293.51 - $383.83 $2.45 Million - $3.2 Million	-8,334 Reduced 6.45%	120,863 $42.7 Million
Q2 2018 Jul 11, 2018	SELL	$257.52 - $306.91 $1.61 Million - $1.91 Million	-6,234 Reduced 4.6%	129,197 $37.5 Million
Q1 2018 Apr 12, 2018	SELL	$260.13 - $367.91 $1.54 Million - $2.18 Million	-5,936 Reduced 4.2%	135,431 $37.1 Million
Q4 2017 Jan 17, 2018	SELL	$307.64 - $344.58 $2.23 Million - $2.49 Million	-7,238 Reduced 4.87%	141,367 $45 Million
Q3 2017 Oct 16, 2017	BUY	$281.15 - $329.69 $41.8 Million - $49 Million	148,605	148,605 $46.5 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Biogen Inc. Transaction History